KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of GoodwillAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)DivestmentsExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bausch Health Companies (BHC) Change in Receivables (2016 - 2025)

Bausch Health Companies' Change in Receivables history spans 17 years, with the latest figure at -$65.0 million for Q4 2025.

  • For Q4 2025, Change in Receivables fell 162.5% year-over-year to -$65.0 million; the TTM value through Dec 2025 reached $134.0 million, down 37.96%, while the annual FY2025 figure was $134.0 million, 37.96% down from the prior year.
  • Change in Receivables for Q4 2025 was -$65.0 million at Bausch Health Companies, down from $218.0 million in the prior quarter.
  • Across five years, Change in Receivables topped out at $231.0 million in Q3 2023 and bottomed at -$197.0 million in Q1 2022.
  • The 5-year median for Change in Receivables is $58.0 million (2023), against an average of $41.6 million.
  • The largest YoY upside for Change in Receivables was 1047.83% in 2025 against a maximum downside of 274.6% in 2025.
  • A 5-year view of Change in Receivables shows it stood at $52.0 million in 2021, then crashed by 40.38% to $31.0 million in 2022, then crashed by 38.71% to $19.0 million in 2023, then surged by 447.37% to $104.0 million in 2024, then tumbled by 162.5% to -$65.0 million in 2025.
  • Per Business Quant, the three most recent readings for BHC's Change in Receivables are -$65.0 million (Q4 2025), $218.0 million (Q3 2025), and $91.0 million (Q2 2025).